Safety profile of oral and intravenous moxifloxacin: Cumulative data from clinical trials and postmarketing studies
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference63 articles.
1. Fluoroquinolone adverse effects and drug interactions;Fish;Pharmacotherapy,2001
2. Safety of the new fluoroquinolones compared with ciprofloxacin;Ball;J Chemother,2000
3. Temafloxacin syndrome: Review of 95 cases;Blum;Clin Infect Dis.,1994
4. Comparative tolerability of the newer fluoroquinolone antibacterials;Ball;Drug Saf.,1999
5. Acute eosinophilic hepatitis from trovafloxacin;Chen;N Engl J Med.,2000
Cited by 99 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-12
2. Propriétés allergiques et activatrices de MRGPRX2 des médicaments : vers un algorithme mécanistique résolutif;Revue Française d'Allergologie;2024-09
3. Safety and tolerability of moxifloxacin in pediatric population: A systematic review of evidence based practice;Tropical Journal of Pharmaceutical Research;2024-04-14
4. Moxifloxacin monotherapy for treatment of uncomplicated pelvic inflammatory disease: A systematic review and meta‐analysis with trial sequential analysis of randomized controlled trials;Pharmacoepidemiology and Drug Safety;2023-09
5. Drug Allergy Practice Parameter Updates to Incorporate Into Your Clinical Practice;The Journal of Allergy and Clinical Immunology: In Practice;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3